Sign in

CIK 0001782223

  • Emerging growth company

Pyxis Oncology, Inc.

Sign in to watch
Ticker
PYXS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831160910
Phone
+1 617-221-9059
Business address
321 HARRISON AVENUE, BOSTON, MA, 02118
  1. 3 Insider Initial Statement of Ownership
  2. 4 Derivatives Options or other derivatives
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 4 Insider Changes in Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 4 Open-market sale Former Director sold 1,745,761 shares at $3.05 ($5,324,571)
  8. 4 Grant or award Chief Financial Officer acquired 93,493 shares (grant or award)
  9. 4 Grant or award Chief Medical Officer acquired 115,931 shares (grant or award)
  10. 4 Grant or award Chief Executive Officer acquired 315,273 shares (grant or award)
  11. 4 Grant or award Director acquired 66,831 shares (grant or award)
  12. 4 Grant or award Chief Medical Officer acquired 306,930 shares (grant or award)
  13. 4 Grant or award Chief Executive Officer acquired 742,574 shares (grant or award)
  14. 4 Grant or award Director acquired 66,831 shares (grant or award)
  15. 4 Grant or award Director acquired 66,831 shares (grant or award)
  16. 4 Grant or award Director acquired 66,831 shares (grant or award)
  17. 4 Grant or award Chief Financial Officer acquired 247,524 shares (grant or award)
  18. 4 Grant or award Director acquired 66,831 shares (grant or award)
  19. 4 Open-market buy Director bought 10,000 shares at $9.39 ($93,885)
  20. 4 Derivatives Options or other derivatives

Page 5 of 7 · 126 filings